Rabbitturd getting chased around the briar patch this afternoon. Here's a copy of a post from Daubers UP at the swamp for those who don't have the stomach to look at the bullshit over there. A few other nice jabs by others too.
And let's not forget that the Cocks are in action tonight against the Baylor Bears in the Sweet 16 matchup at Madison Square Garden. Tipoff scheduled at 7:19.
GO GAMECOCKS!!!!
DaubersUP Friday, 03/24/17 01:38:28 PM
Re: TheBunny post# 176226
Post # of 176244
Bunny what happened to this kind of excitement?
____________________________________________
TheBunny Monday, 11/05/12 08:51:14 AM
Re: NotRichYet2 post# 10542
Post #
10545
of 176230 Go
>>HOW CAN A STOCK WITH A CURE FOR 50% of all cancers be selling at 92 cents ?<<
I know this questions is directed to Bioman but my take; If it wasn't for all the micro scammers in the last few years promising that they got the cure for the world, then just diluting their stockholders to near zero so a few insiders can 'Live Large', we would normally be about $3.50 range at this stage with all things considered.
Also the clobbering in 2008 got many to shun away as many unloaded at the bottom never to come back.
Investors been stung on so many of these 'Cure-all's that are 'just around the corner'. I have been. Ask any veteran mini-bio investor.
CTIX is so different and such a pleasure and welcome change to the others out there. Here we have a CEO that answer questions and gives as many details as he can to his stockholders. Other places when for months stockholders ask management 'Where is TOX?', it just goes unanswered.
I do believe we will see a healthy adjustment in share price when dosing PR is released and more so when results are published.
Investors want to see a bit more now-a-days before dipping in.
However they will miss the rapid growth if test results are outstanding but that's the trade off. As I have said before; Investor nature in some is such that they are more willing to buy something at $4.00 as that number seems to have 'value' and it's 'growing', rather than take the same set of circumstances in a pipeline and it's a $1.00, well hey, there not much value there...'hovering too close to the ground'. Lot of it is psychological. Topic for another day.
Watch how many start coming on here when we are over $2.00. Then when we get uplisted.
But now, the great unwashed feeling a bit unsure about Uncle Billy's recommendation will ask their broker for their opinion. What do you think the broker will say when they know zip about CTIX, and they would prefer to sell them something where he gets a extra 'back-door' commish ?
-bunny-
_______________________________________________________
In late 2012 CTIX had about 93 Million OS - and was just about to dose the first patient in the K phase 1 trial.
So no active trials yet. Here is the PR for the first patient being recruited and enrolled about - 3 days after your post above.
http://www.cellceutix.com/press-release/2016/...-hospitals
http://www.cellceutix.com/press-release/2016/...g-kevetrin
_______________________________________
You were so excited about Leo and CTIX and they did not even have one HUMAN clinical trial dosing??? They only had a dream of Prurisol and were just about start dosing K. So now look at your attitude. I can actually see when you turned looking back - post by post.
So you were screaming this should have been in the 3.50 range back then with zero human clinical results and only 2 drugs on the pipeline....
Fast forward 4-5 years and we added Brilacidin and completed SEVERAL major HUMAN clinical trials with STELLAR results and you are now screaming this should be .60? Hmmmmmmmmmmmmmmmmmm?
And better yet - CTIX did all of this with only diluting 30 million shares? That is 30 million shares to buy a potential multi-billion or multi-blockbuster compound (
and the entire platform, took K through a multi year successful phase 1, started a phase 2 Ovarian trial, completed a couple Prurisol trials and currently in a 2B showing much promise, have B Absssi phase 3 chilling with dominant data comparing it to Dapto from CTIX's phase 2B, OM phase 2 about to deliver interim results, PoC phase 2 UP/UPS onto the final cohort with excellent data thus far, and the list goes on......
So if 3.50 was your price back in late 2012 with zero clinical trials to boot and only P and K! What do you really value CTIX at now?
TIA
Daub
And let's not forget that the Cocks are in action tonight against the Baylor Bears in the Sweet 16 matchup at Madison Square Garden. Tipoff scheduled at 7:19.
GO GAMECOCKS!!!!
DaubersUP Friday, 03/24/17 01:38:28 PM
Re: TheBunny post# 176226
Post # of 176244
Bunny what happened to this kind of excitement?
____________________________________________
TheBunny Monday, 11/05/12 08:51:14 AM
Re: NotRichYet2 post# 10542
Post #
10545
of 176230 Go
>>HOW CAN A STOCK WITH A CURE FOR 50% of all cancers be selling at 92 cents ?<<
I know this questions is directed to Bioman but my take; If it wasn't for all the micro scammers in the last few years promising that they got the cure for the world, then just diluting their stockholders to near zero so a few insiders can 'Live Large', we would normally be about $3.50 range at this stage with all things considered.
Also the clobbering in 2008 got many to shun away as many unloaded at the bottom never to come back.
Investors been stung on so many of these 'Cure-all's that are 'just around the corner'. I have been. Ask any veteran mini-bio investor.
CTIX is so different and such a pleasure and welcome change to the others out there. Here we have a CEO that answer questions and gives as many details as he can to his stockholders. Other places when for months stockholders ask management 'Where is TOX?', it just goes unanswered.
I do believe we will see a healthy adjustment in share price when dosing PR is released and more so when results are published.
Investors want to see a bit more now-a-days before dipping in.
However they will miss the rapid growth if test results are outstanding but that's the trade off. As I have said before; Investor nature in some is such that they are more willing to buy something at $4.00 as that number seems to have 'value' and it's 'growing', rather than take the same set of circumstances in a pipeline and it's a $1.00, well hey, there not much value there...'hovering too close to the ground'. Lot of it is psychological. Topic for another day.
Watch how many start coming on here when we are over $2.00. Then when we get uplisted.
But now, the great unwashed feeling a bit unsure about Uncle Billy's recommendation will ask their broker for their opinion. What do you think the broker will say when they know zip about CTIX, and they would prefer to sell them something where he gets a extra 'back-door' commish ?
-bunny-
_______________________________________________________
In late 2012 CTIX had about 93 Million OS - and was just about to dose the first patient in the K phase 1 trial.
So no active trials yet. Here is the PR for the first patient being recruited and enrolled about - 3 days after your post above.
http://www.cellceutix.com/press-release/2016/...-hospitals
http://www.cellceutix.com/press-release/2016/...g-kevetrin
_______________________________________
You were so excited about Leo and CTIX and they did not even have one HUMAN clinical trial dosing??? They only had a dream of Prurisol and were just about start dosing K. So now look at your attitude. I can actually see when you turned looking back - post by post.
So you were screaming this should have been in the 3.50 range back then with zero human clinical results and only 2 drugs on the pipeline....
Fast forward 4-5 years and we added Brilacidin and completed SEVERAL major HUMAN clinical trials with STELLAR results and you are now screaming this should be .60? Hmmmmmmmmmmmmmmmmmm?
And better yet - CTIX did all of this with only diluting 30 million shares? That is 30 million shares to buy a potential multi-billion or multi-blockbuster compound (
and the entire platform, took K through a multi year successful phase 1, started a phase 2 Ovarian trial, completed a couple Prurisol trials and currently in a 2B showing much promise, have B Absssi phase 3 chilling with dominant data comparing it to Dapto from CTIX's phase 2B, OM phase 2 about to deliver interim results, PoC phase 2 UP/UPS onto the final cohort with excellent data thus far, and the list goes on...... So if 3.50 was your price back in late 2012 with zero clinical trials to boot and only P and K! What do you really value CTIX at now?
TIA
Daub
5
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Lord, help me to be the person that my dogs think I am...
